Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia. (Q44139133)

From Wikidata

Jump to navigation Jump to search

scientific article published in September 2002

Language	Label	Description	Also known as
English	Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia.	scientific article published in September 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12235527%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12235527%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

based on heuristic

inferred from title

Dmitry Balashov

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12235527%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

Maschan AA

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12235527%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Skorobogatova EV

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12235527%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Pashanov ED

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12235527%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Trakhtman PE

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12235527%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Schipitzina IP

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12235527%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Skvortsova YV

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12235527%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Rumiantzev AG

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12235527%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12235527%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12235527%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12235527%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12235527%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

405-407

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12235527%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Pure red cell aplasia after ABO-incompatible allogeneic stem cell transplantation in severe aplastic anemia with response to steroids: a case report and literature review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703668

21 January 2018

CD34+-enriched donor lymphocyte infusions in a case of pure red cell aplasia and late graft failure after major ABO-incompatible bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703668

21 January 2018

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703668

21 January 2018

Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703668

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703668

7 January 2021

based on heuristic

inferred from DOI database lookup

Pure red cell aplasia after allogeneic stem cell transplantation with reduced conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703668

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: a case report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703668

7 January 2021

based on heuristic

inferred from DOI database lookup

Apheresis Therapy for Prolonged Red Cell Aplasia after Major ABO-Mismatched Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703668

7 January 2021

based on heuristic

inferred from DOI database lookup

Donor lymphocyte infusion as therapy for pure red cell aplasia following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703668

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703668

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703668

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12235527%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

release_4ih5edmk2vfcpf5pf43qorcfna

1 reference

https://api.fatcat.wiki/v0/release/4ih5edmk2vfcpf5pf43qorcfna

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12235527%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44139133&oldid=2235352018"